AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pacira BioSciences, Inc. Director's Dealing 2021

Jun 8, 2021

32125_dirs_2021-06-08_8469f359-423e-41df-bd91-d7b211ea9e94.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pacira BioSciences, Inc. (PCRX)
CIK: 0001396814
Period of Report: 2021-06-04

Reporting Person: HASTINGS PAUL J (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-04	Common Stock	S	630	$62.19	Disposed	5486	Direct

Footnotes

F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F2: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.